SCHEMBL7047751

SCHEMBL7047751

O=C(NS(=O)(=O)c1ccccc1NC(=O)c1cccc(OCc2ccccc2)c1)Oc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 2/20 0.55
NR1H4 Q96RI1 3/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
TSHR P16473 2/20 0.53
ALDH1A1 P00352 1/20 0.53
GAA P10253 1/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
BCL2L1 Q07817 1/20 0.51
MCL1 Q07820 1/20 0.51
NR4A2 P43354 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
FAAH O00519 1/20 0.48
CNR2 P34972 1/20 0.48
GPR132 Q9UNW8 1/20 0.48
SRD5A2 P31213 1/20 0.48
MAOB P27338 1/20 0.48
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052824 0.92 SMPD1 (0.62) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7045604 0.91 SMPD1 (0.61) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7045371 0.89 KMT2A (0.62) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7076910 0.88 HDAC1 (0.59) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7044608 0.86 SMPD1 (0.53) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7078520 0.85 ALDH1A1 (0.53) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7076463 0.85 SMPD1 (0.52) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7083454 0.84 SMPD1 (0.54) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7082518 0.84 SMPD1 (0.54) SMPD1NR1H4HDAC1HDAC8HDAC6
SCHEMBL7077932 0.84 HDAC1 (0.58) SMPD1NR1H4HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN SMPD1 760/4885NR1H4 1199/4885HDAC1 271/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 SMPD1 156/4885NR1H4 1277/4885HDAC1 305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.